EMJ Hematology 9 [Supplement 5] . 2021

This interactive article summarises key discussions from GSK sponsored symposia that took place during the ESCMID Global Congress 2024, held from 27–30th April 2024 in Barcelona, Spain. Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content. Thank you! Please share some more information on the rating you have given Submit Feedback

AIHA is an acquired, heterogeneous group of rare diseases with a prevalence of 17 per 100,000.1 This group includes wAIHA… Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content. Thank you! Please share some more information on the rating you have given Submit Feedback

Myelodysplastic syndromes are a group of disorders that affect the bone marrow, subsequently affecting the growth and relative… Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content. Thank you! Please share some more information on the rating you have given Submit Feedback

Diffuse large B cell lymphoma (DLBCL) is the most common histological subtype of non-Hodgkin’s lymphoma. However, splenic DLBCL is a… Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content. Thank you! Please share some more information on the rating you have given Submit Feedback